Latest Earnings Results: Q3 '26
Estimated EPS
$1.45
Reported EPS
$1.44
Surprise
-0.65%
Estimated Rev
$2.28B
Reported Rev
$2.2B
Surprise
-3.46%
• Reported GAAP EPS of $1.44 up 5.11% YoY • Reported revenue of $2.2B down -2.95% YoY • Xylem forecasts full-year 2026 revenue of approximately $8.95B, down 1 percent on a reported basis and flat organically; adjusted EBITDA margin approximately 23.2 percent and adjusted EPS $5.40 to $5.45.
Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q4 '26 | $1.44 | -- | -- | N/A |
Q3 '26 | $1.45 | $1.44 | -0.65% | MISSED |
Q2 '26 | $1.34 | $1.46 | 9.18% | BEAT |
Q1 '26 | $1.08 | $1.12 | 3.24% | BEAT |
Q4 '25 | $1.41 | $1.42 | 0.81% | BEAT |